High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 162 participants.
Also called NCT05912686
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 162 participants
- Sponsor
- Registry
-
NCT05912686
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05912686. Randomized; no masking; primary purpose treatment. Start 2023-07-01 (anticipated); primary completion 2025-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
- Condition
- Mechanical Thrombectomy
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Atorvastatin 80mg
- Intervention (Drug)
- Atorvastatin 20mg
- Lead sponsor
- Zhongda Hospital
Record details
- Record id
cardio:ct-nct05912686- Content hash
a1a6b99a31d76469035b03a4d641983e94f8da38b9a40d4b6adc5a464ce9701d